Delay between stroke onset and emergency department evaluation

Neuroepidemiology

Volumn 20, Issue 3, 2001, Pages 196-200

  Goldstein, Larry B ^a,b,c   Edwards, M G ^a   Wood, D P ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Education; Health services; Stroke; Thrombolytics; Tissue plasminogen activator

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; DISEASE SEVERITY; EMERGENCY WARD; EVALUATION; FEMALE; FIBRINOLYTIC THERAPY; HEALTH EDUCATION; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SCORING SYSTEM; STROKE; SYMPTOM;

AGE FACTORS; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0034902225     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054787     Document Type: Article

References (20)

1. Delayed hospital arrival for acute stroke: The Minnesota Stroke Survey
2. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience
3. Factors delaying hospital admission in acute stroke: The Copenhagen Stroke Study
4. A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke
5. Classification and natural history of clinically identifiable subtypes of cerebral infarction
6. Retrospective assessment of initial stroke severity with the Ca-nadian Neurological Scale
7. Delay in neurological attention and stroke outcome
8. Factors predictive of stroke outcome in a rehabilitation setting
9. Stroke patients' knowledge of stroke. Influence on time to presentation
10. The Greater Cincinnati/Northern Kentucky Stroke Study: Preliminary first-ever and total incidence rates of stroke among blacks
11. Tissue plasminogen activator for acute ischemic stroke
12. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study
13. Is the stroke belt disappearing? An analysis of racial, temporal, and age effects
14. North Carolina Stroke Prevention and Treatment Facilities Survey: State-wide availability of programs and services
15. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients
16. Public perception of stroke warning signs and knowledge of potential risk factors
17. Stroke-related knowledge among patients with access to medical care in the Stroke Belt
18. The delay in reporting symptoms of carotid artery stenosis in an at-risk population. The Asymptomatic Carotid Atherosclerosis Study experience: A statement of concern regarding watchful waiting
19. Knowledge of risk among patients at increased risk for stroke
20. Utilities for major stroke: Results from a survey of preferences among persons at increased risk for stroke